Associated Papers
Genotype-phenotype correlation and natural history analyses in a Chinese cohort with pelizaeus-merzbacher disease.
Duan R et al.
Orphanet Journal of Rare Diseases, 2022
When glia meet induced pluripotent stem cells (iPSCs).
Li L et al.
Molecular and Cellular Neurosciences, 2020
Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
Elitt MS et al.
Stem Cell Reports, 2018
Induction of myelinating oligodendrocytes in human cortical spheroids.
Madhavan M et al.
Nature Methods, 2018
Exome sequencing reveals a novel PLP1 mutation in a Moroccan family with connatal Pelizaeus-Merzbacher disease: a case report.
Lyahyai J et al.
Bmc Pediatrics, 2018
Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.
Ji H et al.
Plos One, 2018
29451896 (PubMed )
Supplement: pone.0188869.s005.xlsx › _S5_Table
Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS et al.
American Journal of Human Genetics, 2017
Diffusion tensor imaging of patients with proteolipid protein 1 gene mutations.
Laukka JJ et al.
Journal of Neuroscience Research, 2014
Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease.
Laukka JJ et al.
Journal of the Neurological Sciences, 2013
Select a paper to view details